The emerging treatment of the medication represents a major breakthrough in the handling of the condition. Unlike existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide203906.blogscribble.com/42319863/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment